Fit For Your Company:
UnknownEnter your company details to see if Mark Rothera is a good fit as an investor for your company.
Enter Your CompanyMark Rothera
President and Chief Executive Officer at Silence Therapeutics
Summit, United States
Invests in Biotechnology, Health Care, Information Technology
Seed, Early, Growth, Pre-Seed, Series A
Upgrade to Funden Lite to see Mark Rothera's email address
Upgrade to Funden Lite to see Mark Rothera's LinkedIn profile